The Effect of Reducing Sedentary Behaviour in Comparison to Promoting Physical Activity on Chronic Non-specific Low Back Pain in a Sedentary Population

May 6, 2024 updated by: Malfliet Anneleen, Vrije Universiteit Brussel
The investigators will recruit participants between the age of 18 and 65 with chronic non-specific low back pain and a sedentary lifestyle. The participants will be randomly assigned to one of the three groups. The first group is the control group, the participants will be asked to continue their daily routine. The second group is an intervention group, sedentary behaviour will be reduced. In the third group participants will be asked to increase their physical activity up to 150min/week. The intervention takes place over a period of 6 weeks. After the intervention the pressure pain threshold will be measured, average steps will be measured (accelerometer) and a questionnaire needs to be filled out. These results will be compared to the results before the intervention and to the results of the other groups.

Study Overview

Detailed Description

The investigators will recruit participants between the age of 18 and 65 with chronic non-specific low back pain and a sedentary lifestyle. The partcipants will be randomly assigned to one of the three groups. The first group is the control group, the participants will be asked to not change their daily routine. In the first intervention group sedentary behaviour will be reduced. The participants will be asked to download an app on their smartphone and computer. This app will ask the participants to stand up and walk during 2 minutes to interrupt their sedentary behaviour during working hours. In the second intervention group participants will be asked to increase their physical activity. More specifically the participants will be asked to be active for a period of 150min/week. The intervention takes place over a period of 6 weeks. During these 6 weeks the participants needs to wear an accelerometer the first and the last week of the intervention. The week before the intervention a pre-measurement will take place, this means that the participant needs to wear an accelerometer during a week, fill out a questionnaire (BPI and SF-36) and the pressure pain threshold will be measured. After the intervention (6 weeks) the pressure pain threshold will be measured, average steps will be measured (accelerometer) and a questionnaire needs to be filled out. These results will be compared to the results before the intervention and to the results of the other groups. With this study the investigators will investigate whether less sedentary behavior or more physical activity are beneficial for chronic low-back pain.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Brussels Hoofdstedelijk Gewest
      • Jette, Brussels Hoofdstedelijk Gewest, Belgium, 1090
        • Vrije Universiteit Brussel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • CNLBP, for at least 3days/week for at least 3 months since the first symptoms.
  • Failed back surgery syndrome is allowed (ie, more than 3 years ago, anatomically successful operation without symptom disappearance)
  • Desk job, sedentary lifestyle (i.e. sitting for more than 6 hours per day). Given the greater risk of developing serious health problems when sitting for more than six hours a day.
  • 18-65 years old
  • Native Dutch speaker
  • Refraining from analgesics, caffeine, alcohol or nicotine in the previous 48h of the assessments
  • Not undertaking exercise (>3 metabolic equivalents) 3 days before the assessments
  • Both sexes
  • Experiencing chronic neck pain is allowed if CNLBP is the dominant complaint.

Exclusion Criteria:

  • Any specific cause that can explain the CNLBP
  • Physically demanding job (e.g. nurses, paramedics, construction workers,...)
  • Chronic widespread pain (i.e. fibromyalgia, chronic fatigue syndrome)
  • Chronic systematic diseases such as rheumatoid arthritis, diabetes, etc.
  • Neuropathic pain
  • Being pregnant or pregnancy (including giving birth) in the preceding year
  • History of specific spinal surgery
  • Cinical depression

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
This group will be asked to maintain their daily routine.
Experimental: Reducing sedentary behavior
This group needs to download an app on their computer and their smartphone. This app will give a notification every 30 minutes to walk during 2 minutes during working hours.
This group needs to download an app on their computer and their smartphone. This app will give a notification every 30 minutes to walk during 2 minutes during working hours. The participants will receive a diary to write down whether they stand up.
Experimental: Increase physical activity
This group will be asked to be more physically active. They need to be active during 150min/week. Additionnaly they need to be active in periods of at least 10 minutes.
This group will be asked to be more physically active. They need to be active during 150min/week. It can include walking, to ride a bike, jogging, tennis, football,... Additionnaly they need to be active in periods of at least 10 minutes. The participants will receive a diary to write down which activity they did and also for how long.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Brief Pain Inventory (short form)
Time Frame: Baseline assessment (T0)
Since chronic pain is a rather fluctuating condition, the question "Please rate your pain by circling the one number that best describes your pain on AVERAGE" is used as primary outcome measure to evaluate pain intensity. The answer to this question is formulated on an 11-point (i.e. 0-10) numeric rating scale (NRS), which is recommended as a core outcome measure in clinical trials of chronic pain. 0 indicates no pain, 10 indicates the worst pain imaginable.
Baseline assessment (T0)
The Brief Pain Inventory (short form)
Time Frame: Directly post-intervention (6 weeks after baseline assessement)
Since chronic pain is a rather fluctuating condition, the question "Please rate your pain by circling the one number that best describes your pain on AVERAGE" is used as primary outcome measure to evaluate pain intensity. The answer to this question is formulated on an 11-point (i.e. 0-10) numeric rating scale (NRS), which is recommended as a core outcome measure in clinical trials of chronic pain. 0 indicates no pain, 10 indicates the worst pain imaginable.
Directly post-intervention (6 weeks after baseline assessement)
The Brief Pain Inventory (short form)
Time Frame: 3 month follow-up
Since chronic pain is a rather fluctuating condition, the question "Please rate your pain by circling the one number that best describes your pain on AVERAGE" is used as primary outcome measure to evaluate pain intensity. The answer to this question is formulated on an 11-point (i.e. 0-10) numeric rating scale (NRS), which is recommended as a core outcome measure in clinical trials of chronic pain. 0 indicates no pain, 10 indicates the worst pain imaginable.
3 month follow-up
The Brief Pain Inventory (short form)
Time Frame: 6 month follow-up (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)
Since chronic pain is a rather fluctuating condition, the question "Please rate your pain by circling the one number that best describes your pain on AVERAGE" is used as primary outcome measure to evaluate pain intensity. The answer to this question is formulated on an 11-point (i.e. 0-10) numeric rating scale (NRS), which is recommended as a core outcome measure in clinical trials of chronic pain. 0 indicates no pain, 10 indicates the worst pain imaginable.
6 month follow-up (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Algometry (pressure pain threshold)
Time Frame: Baseline assessment (T0)
Pressure pain thresholds will be assessed by using a handheld digital algometer. It evaluates the lowest stimulus in which a person perceives pain.
Baseline assessment (T0)
Algometry (pressure pain threshold)
Time Frame: Directly post-intervention (6 weeks after baseline assessement)
Pressure pain thresholds will be assessed by using a handheld digital algometer. It evaluates the lowest stimulus in which a person perceives pain.
Directly post-intervention (6 weeks after baseline assessement)
Algometry (pressure pain threshold)
Time Frame: 3 month follow-up
Pressure pain thresholds will be assessed by using a handheld digital algometer. It evaluates the lowest stimulus in which a person perceives pain.
3 month follow-up
Algometry (pressure pain threshold)
Time Frame: 6 month follow-up. (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)
Pressure pain thresholds will be assessed by using a handheld digital algometer. It evaluates the lowest stimulus in which a person perceives pain.
6 month follow-up. (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)
The Brief Pain Inventory (Short form)
Time Frame: Baseline Assessment (T0)
The BPI is a questionnaire to assess pain severity and degree of interference in daily functioning. Scores range from 0 to 10, with higher scores indicating more pain, or more pain interference.
Baseline Assessment (T0)
The Brief Pain Inventory (Short form)
Time Frame: Directly post-intervention (6 weeks after baseline assessement)
The BPI is a questionnaire to assess pain severity and degree of interference in daily functioning. Scores range from 0 to 10, with higher scores indicating more pain, or more pain interference.
Directly post-intervention (6 weeks after baseline assessement)
The Brief Pain Inventory (Short form)
Time Frame: 3 month follow-up
The BPI is a questionnaire to assess pain severity and degree of interference in daily functioning. Scores range from 0 to 10, with higher scores indicating more pain, or more pain interference.
3 month follow-up
The Brief Pain Inventory (Short form)
Time Frame: 6 month follow-up (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)
The BPI is a questionnaire to assess pain severity and degree of interference in daily functioning. Scores range from 0 to 10, with higher scores indicating more pain, or more pain interference.
6 month follow-up (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)
Accelerometry (objective measures of physical activity and sedentary behavior)
Time Frame: Baseline assessment (T0)
With a hip-worn accelerometer sedentary behavior and physical acitvity will be objectively measured.
Baseline assessment (T0)
Accelerometry (objective measures of physical activity and sedentary behavior)
Time Frame: Directly post-intervention (6 weeks after baseline assessement)
With a hip-worn accelerometer sedentary behavior and physical acitvity will be objectively measured.
Directly post-intervention (6 weeks after baseline assessement)
Short Form 36 Health Status Survey (SF-36)
Time Frame: Baseline assessment (T0)
The SF-36 is a questionnaire to consider the health- related quality of life. Scores on the SF36 range from 0 to 400, with higher scores indicating better health.
Baseline assessment (T0)
Short Form 36 Health Status Survey (SF-36)
Time Frame: Directly post-intervention (6 weeks after baseline assessement)
The SF-36 is a questionnaire to consider the health- related quality of life. Scores on the SF36 range from 0 to 400, with higher scores indicating better health.
Directly post-intervention (6 weeks after baseline assessement)
Short Form 36 Health Status Survey (SF-36)
Time Frame: 3 month follow-up
The SF-36 is a questionnaire to consider the health- related quality of life. Scores on the SF36 range from 0 to 400, with higher scores indicating better health.
3 month follow-up
Short Form 36 Health Status Survey (SF-36)
Time Frame: 6 month follow-up ( (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)
The SF-36 is a questionnaire to consider the health- related quality of life. Scores on the SF36 range from 0 to 400, with higher scores indicating better health.
6 month follow-up ( (go/ no go principe = if there is still a difference in behaviour between the groups after 3 months, we organize a 6m follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anneleen Malfliet, Prof. Dr., Vrije Universiteit Brussel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2020

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

October 15, 2020

First Submitted That Met QC Criteria

October 26, 2020

First Posted (Actual)

November 2, 2020

Study Record Updates

Last Update Posted (Actual)

May 8, 2024

Last Update Submitted That Met QC Criteria

May 6, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B1432020000219

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe